News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
651,815 Results
Type
Article (61879)
Company Profile (139)
Press Release (589797)
Multimedia
Podcasts (60)
Webinars (13)
Section
Business (175606)
Career Advice (2751)
Deals (32711)
Drug Delivery (100)
Drug Development (77319)
Employer Resources (156)
FDA (15051)
Job Trends (14048)
News (308080)
Policy (29554)
Tag
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (15)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (4)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (2)
2026 BioCapital Standard (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Genetown Standard (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2896)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (85)
Alliances (43689)
ALS (89)
Alzheimer's disease (1323)
Antibody-drug conjugate (ADC) (112)
Approvals (15063)
Artificial intelligence (258)
Autoimmune disease (23)
Automation (15)
Bankruptcy (298)
Best Places to Work (10957)
BIOSECURE Act (16)
Biosimilars (105)
Biotechnology (95)
Bladder cancer (68)
Brain cancer (26)
Breast cancer (267)
Cancer (2102)
Cardiovascular disease (163)
Career advice (2326)
Career pathing (33)
CAR-T (148)
Cell therapy (412)
Cervical cancer (20)
Clinical research (62742)
Collaboration (772)
Compensation (326)
Complete response letters (22)
COVID-19 (2579)
CRISPR (40)
C-suite (251)
Cystic fibrosis (102)
Data (2046)
Decentralized trials (2)
Denatured (25)
Depression (41)
Diabetes (247)
Diagnostics (6197)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (41)
Drug discovery (113)
Drug pricing (97)
Drug shortages (23)
Duchenne muscular dystrophy (86)
Earnings (60943)
Editorial (38)
Employer branding (18)
Employer resources (136)
Events (96460)
Executive appointments (741)
FDA (16262)
Featured Employer (28)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (743)
Gene editing (105)
Generative AI (20)
Gene therapy (285)
GLP-1 (673)
Government (4484)
Grass and pollen (6)
Guidances (49)
Healthcare (18460)
Huntington's disease (19)
IgA nephropathy (22)
Immunology and inflammation (107)
Indications (27)
Infectious disease (2712)
Inflammatory bowel disease (134)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (92)
Interviews (527)
IPO (14894)
IRA (39)
Job creations (3478)
Job search strategy (1956)
Kidney cancer (10)
Labor market (31)
Layoffs (504)
Leadership (20)
Legal (6788)
Liver cancer (67)
Lung cancer (298)
Lymphoma (139)
Machine learning (6)
Management (54)
Manufacturing (277)
MASH (62)
Medical device (12886)
Medtech (12891)
Mergers & acquisitions (18371)
Metabolic disorders (627)
Multiple sclerosis (76)
NASH (13)
Neurodegenerative disease (82)
Neuropsychiatric disorders (26)
Neuroscience (1828)
NextGen: Class of 2025 (6452)
Non-profit (4413)
Northern California (2383)
Now hiring (23)
Obesity (324)
Opinion (233)
Ovarian cancer (70)
Pain (86)
Pancreatic cancer (77)
Parkinson's disease (141)
Partnered (21)
Patents (228)
Patient recruitment (105)
Peanut (50)
People (59727)
Pharmaceutical (35)
Pharmacy benefit managers (15)
Phase I (19729)
Phase II (27674)
Phase III (20250)
Pipeline (1085)
Policy (123)
Postmarket research (2497)
Preclinical (8428)
Press Release (67)
Prostate cancer (100)
Psychedelics (27)
Radiopharmaceuticals (249)
Rare diseases (360)
Real estate (6063)
Recruiting (63)
Regulatory (20295)
Reports (34)
Research institute (2414)
Resumes & cover letters (410)
Rett syndrome (4)
RNA editing (3)
RSV (35)
Schizophrenia (66)
Series A (130)
Series B (85)
Service/supplier (11)
Sickle cell disease (51)
Southern California (2091)
Special edition (11)
Spinal muscular atrophy (147)
Sponsored (29)
Startups (3392)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (24)
The Weekly (33)
United States (20878)
Vaccines (658)
Venture capitalists (34)
Weight loss (209)
Women's health (30)
Worklife (18)
Date
Today (53)
Last 7 days (616)
Last 30 days (2269)
Last 365 days (30731)
2025 (9424)
2024 (32670)
2023 (36808)
2022 (47034)
2021 (51945)
2020 (51116)
2019 (45240)
2018 (34478)
2017 (31005)
2016 (30420)
2015 (35870)
2014 (28797)
2013 (25308)
2012 (26612)
2011 (26878)
2010 (25272)
Location
Africa (883)
Alabama (55)
Alaska (6)
Arizona (176)
Arkansas (14)
Asia (38252)
Australia (6897)
California (5526)
Canada (1808)
China (469)
Colorado (244)
Connecticut (250)
Delaware (133)
Europe (88853)
Florida (826)
Georgia (195)
Idaho (56)
Illinois (533)
India (25)
Indiana (279)
Iowa (10)
Japan (150)
Kansas (95)
Kentucky (23)
Louisiana (10)
Maine (61)
Maryland (814)
Massachusetts (3899)
Michigan (219)
Minnesota (332)
Mississippi (2)
Missouri (87)
Montana (29)
Nebraska (23)
Nevada (54)
New Hampshire (60)
New Jersey (1608)
New Mexico (29)
New York (1579)
North Carolina (964)
North Dakota (8)
Northern California (2383)
Ohio (189)
Oklahoma (15)
Oregon (37)
Pennsylvania (1196)
Puerto Rico (11)
Rhode Island (30)
South America (1188)
South Carolina (18)
South Dakota (1)
Southern California (2091)
Tennessee (95)
Texas (824)
Utah (169)
Virginia (140)
Washington D.C. (50)
Washington State (517)
West Virginia (3)
Wisconsin (58)
651,815 Results for "university of california davis".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Layoffs
Q1 Biopharma Layoffs Hit California, Massachusetts Hard
During the first quarter, 22 rounds of biopharma layoffs in California affected about 995 employees total, while 17 rounds in Massachusetts impacted around 410 people, based on
BioSpace
estimates. Meanwhile, competition for jobs in those states increased year over year, according to
BioSpace
data.
April 17, 2025
·
5 min read
·
Angela Gabriel
Press Releases
Santa Clara University and Biocom California Institute Partner to Advance Biomanufacturing Workforce Development
March 19, 2025
·
5 min read
Press Releases
SIFI announces collaboration with the University of California, San Francisco on Acanthamoeba Keratitis
March 19, 2025
·
5 min read
Job Trends
7 Companies Hiring in California
Job postings in California took a dip in December during the holiday period, but activity is expected to pick up in January.
January 2, 2025
·
1 min read
·
Chantal Dresner
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women
Femasys Inc. today announced that it has activated enrollment for its pivotal FemBloc® trial at University of California, Davis (“UC Davis”) Medical Center in Sacramento, California.
January 26, 2024
·
7 min read
Layoffs
More Layoffs From ImmunityBio, Bringing California’s Fall Cuts to 31
ImmunityBio will lay off 15 employees in California, mostly in El Segundo, effective Nov. 25. The company is also letting go 16 employees later this month.
October 2, 2024
·
1 min read
·
Angela Gabriel
Press Releases
Biocom California Recognizes Akilah Weber Pierson and Kent Lee as Elected Officials of the Year
March 3, 2025
·
3 min read
Press Releases
Biocom California Appoints Two New Members to its Board of Directors
April 10, 2025
·
3 min read
Business
IO Biotech Announces First Patient Dosed in Investigator-Initiated Phase 1 Trial at University of California Davis Comprehensive Cancer Center
IO Biotech announced today that the University of California Davis Comprehensive Cancer Center has dosed the first patient in its investigator-initiated trial which aims to evaluate IO102-IO103, the company’s investigational immune-modulating cancer vaccine.
July 28, 2023
·
4 min read
Press Releases
University of California San Francisco and GE HealthCare Launch a Joint Research Program to Drive Innovations in Imaging, Brain Health and Precision Oncology
January 15, 2025
·
5 min read
1 of 65,182
Next
